Assessment of the efficacy and safety of carbon nanoparticles-guided lymph node dissection in gastric cancer surgery: a systematic review and meta-analysis
- PMID: 37099219
- DOI: 10.1007/s10147-023-02333-x
Assessment of the efficacy and safety of carbon nanoparticles-guided lymph node dissection in gastric cancer surgery: a systematic review and meta-analysis
Abstract
Background: To investigate the efficacy and safety of lymph nodes (LNs) dissection guided by carbon nanoparticles (CNs) in gastric cancer (GC) surgery.
Materials and methods: We searched electronic databases such as PubMed, Web of Science, Embase, Cochrane Library, and Scopus for relevant articles up to September 2022 and collected all studies comparing the CNs group with blank controls group on the efficacy and safety of LN dissection in gastrectomy. A pooled analysis of the collected data was performed, including the number of retrieved LNs, the staining rate of LNs, the number of metastatic LNs dissection, various intraoperative outcomes, and postoperative complications.
Results: A total of 9 studies including 1770 participants (502 in the CNs group and 1268 in the control group) were included. As compared to the blank control group, the CNs group detected 10.46 more LNs in each patient (WMD = 10.46, 95% CI: 6.63 ~ 14.28, p < 0.00001, I2 = 91%), and also significantly more metastatic LNs (WMD = 2.63, 95% CI: 1.43 ~ 3.83, p < 0.0001, I2 = 41%). However, there was no significant difference in the rate of metastatic LNs between the CNs and control groups (OR = 1.37, 95% CI: 0.94 ~ 2.00, P = 0.1, I2 = 89%). In addition, there was no increase in operative time, intraoperative blood loss, and postoperative complications associated with CNs-guided gastrectomy.
Conclusion: CNs-guided gastrectomy is safe and effective, and can increase the efficiency of LN dissection without increasing the risk of surgery.
Keywords: Carbon nanoparticles; Gastrectomy; Gastric cancer; Lymph node; Meta-analysis.
© 2023. The Author(s) under exclusive licence to Japan Society of Clinical Oncology.
References
-
- Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660 - DOI - PubMed
-
- de Jongh C, Triemstra L, van der Veen A et al (2022) Pattern of lymph node metastases in gastric cancer: a side-study of the multicenter logica-trial. Gastric Cancer. https://doi.org/10.1007/s10120-022-01329-2 - DOI - PubMed - PMC
-
- Izumi D, Gao F, Toden S et al (2019) A genomewide transcriptomic approach identifies a novel gene expression signature for the detection of lymph node metastasis in patients with early stage gastric cancer. EBioMedicine 41:268–275. https://doi.org/10.1016/j.ebiom.2019.01.057 - DOI - PubMed - PMC
-
- Zhang CD, Yamashita H, Okumura Y et al (2022) Signature and prediction of perigastric lymph node metastasis in patients with gastric cancer and total gastrectomy: is total gastrectomy always necessary? Cancers (Basel) 14:14. https://doi.org/10.3390/cancers14143409 - DOI
-
- Japanese Gastric Cancer Treatment Guidelines 2018 (5th Edition). Gastric Cancer 24, no. 1 (2021):1–21. https://doi.org/10.1007/s10120-020-01042-y
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous